profit from every $100 of sales.

Morgan Stanley Pathway Small-Mid Cap Equity ETF
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
You pay $40.50 for every $1 of profit it makes in a year.
of earnings would pay off all its debt.
Morgan Stanley Pathway Small-Mid Cap Equity ETF vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
Morgan Stanley Pathway Small-Mid Cap Equity ETF | 40.5× · No profit yet | ||
Petroleo Brasileiro S.A.-Petrobras | 5.8× · Cheap | ||
Companhia Energetica De Minas Gerais-CEMIG | 9.8× · Cheap | ||
Embotelladora Andina S.A. Series B | 16.5× · Fair price | ||
Bluerock Private Real Estate Fund | No profit yet |
AI analysis
An AI analyst reads Morgan Stanley Pathway Small-Mid Cap Equity ETF's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisNo annual statements on file yet.
Valuation
- 40.5×
- –
- –
- –
- –
- –
- –
- –
- 2.5%
- –
Profitability
- –
- –
- –
- –
- –
- 0.0%
- –
- –
- –
- –
Growth
- –
- –
- –
- –
- +0.0%
Financial health
- –
- –
- –
- –
- –
- –
- –
News
Morgan Stanley issues strong opinion on S&P 500Yahoo Finance · Nov 10, 2026Oil prices are set to decline, benefiting equities into 2027 – Morgan Stanley’s Mike WilsonSeeking Alpha · Nov 9, 2026The market’s correction is entering its final phase — but wait before buying the dip, says Morgan Stanley chief strategistMarketWatch · Nov 9, 2026Morgan Stanley Says $300. Michael Burry Says Overvalued. Here's Who Is Right About SpaceX Stock.Yahoo Finance · Nov 8, 2026Morgan Stanley Tokenizes U.S. EquitiesYahoo Finance · Nov 4, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Morgan Stanley Pathway Small-Mid Cap Equity ETF
Is Morgan Stanley Pathway Small-Mid Cap Equity ETF a good stock to buy?
A business with weak numbers that is not profitable yet. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Morgan Stanley Pathway Small-Mid Cap Equity ETF AI analysis
How has Morgan Stanley Pathway Small-Mid Cap Equity ETF stock done over the past year?
Up 11.6% over the past twelve months, to $58.59. It traded between $49.92 and $61.96 and is 5.4% below its high.
Who are Morgan Stanley Pathway Small-Mid Cap Equity ETF's competitors?
The largest listed companies in the same industry are Petroleo Brasileiro S.A.-Petrobras, Companhia Energetica De Minas Gerais-CEMIG, Embotelladora Andina S.A. Series B and Bluerock Private Real Estate Fund. The peers table on this page compares their profit, growth and price with Morgan Stanley Pathway Small-Mid Cap Equity ETF's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.



